Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pharmacists get training to better support cancer patients on oral medications

NCT ID NCT07677176

Knowledge-focused Sponsor: Monash University Malaysia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 15, 2026 · Updated 5 times

Summary

This pilot study tests whether an educational program can help community pharmacists better support patients taking oral anticancer drugs. Thirty registered pharmacists in Malaysia will be randomly assigned to either attend the program or a control group. Researchers will measure how feasible and acceptable the program is, and gather early data on whether it improves pharmacists' knowledge and confidence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Educational intervention on managing oral anticancer agents
What this could lead to
If successful, this program could better equip community pharmacists to support patients taking oral anticancer drugs, potentially improving patient care and safety.
What could go wrong
This is a small pilot study with only 30 participants in Malaysia, so results may not apply broadly. The intervention's impact on actual patient outcomes is not directly measured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Currently a registered pharmacist working in community pharmacy in Malaysia * Provided written informed consent * Ability to read and understand English * Basic digital literacy and ability to use computer/tablet devices * Willingness to participate in all study procedures including surveys and potential interviews Exclusion Criteria: • Previous participation in educational intervention stakeholder evaluation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Oral anti-tumor drugs are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Oral anti-tumor drugs Oral anticancer drugs Oral antineoplastic agents

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Monash University Malaysia

    Subang Jaya, Selangor, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.